For our Executive MBA alumnae, choosing science was not a symbolic act. It was an intellectual decision. Their careers began with curiosity - a genuine interest in mathematics, biology, physics, data, or technologies. Their entry into scientific fields was not framed around gender but around the desire to change the world and future for the better.
Shirine, Associate Director of Business Development Europe at Guardant Health, elaborates:
“To me, science is not a matter of gender, but of intellect. I view myself primarily as a ‘brain’ - an engine for understanding and building knowledge for future generations.”
Joane,Global Head of Evidence at Opella, and Valeria,- Life Sciences and Healthcare Senior Expert at Dassault Systèmes, share a similar position - the latter explains:
“In the end, to me, it is less about being a woman or a man, and more about purpose: the reason you wake up in the morning, go to work, and contribute to society through meaningful impact!”
In both cases, expertise comes first. Gender is acknowledged, but it does not define ambition. What defines their trajectory is rigor, consistency, and the intention to contribute meaningfully.
Their sources of inspiration reflect this mindset. For Houda, working as Head of Data & AI, leadership is grounded in resilience:
“My role model is my mother. She is a warrior in the truest sense and a symbol of resilience. She taught me that it is not about resisting once, but about standing up every day.”
Others describe a mosaic of influences: professors, colleagues, family members, and leaders met across countries and sectors. They draw lessons from these encounters and shape their own approach.
Marie Curie stands out as a historical reference point. Shirine describes her as “a lifelong inspiration for her passion and her ability to make major discoveries in physics during an era - and a field - dominated by men.”
Her legacy highlights a lasting reality: women have always contributed to scientific progress, yet this has not always translated into representation in executive roles. Today, those roles shape funding decisions, regulatory positioning, and commercialization strategies. Access to these positions matters for broader representation in strategic decision-making, and our alumnae are part of this shift.